ViiV Healthcare has initiated a rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for long-acting cabotegravir to prevent human immunodeficiency The post ViiV begins rolling submission for cabotegravir to prevent HIV in US appeared first on Pharmaceutical Business review. … [Read more...]

Specialty life sciences company Revive Therapeutics has signed a research agreement with University of California, San Francisco (UCSF) to study Bucillamine as a potential treatment for severe Covid-19. The post Revive Therapeutics, UCSF partner to study Bucillamine for severe Covid-19 appeared first on Pharmaceutical Business review. … [Read more...]

World Health Organization (WHO) has granted emergency use listing (EUL) for Moderna’s Covid-19 vaccine to prevent the infection in people aged 18 years and above. The Covid-19 Vaccine The post WHO grants emergency use listing for Moderna’s Covid-19 vaccine appeared first on Pharmaceutical Business review. … [Read more...]

Biopharmaceutical company CANbridge Pharmaceuticals has signed a licensing agreement with Mirum Pharmaceuticals for the development and commercialisation of maralixibat in Greater China. Maralixibat is a minimally absorbed, orally The post CANbridge signs license agreement with Mirum for maralixibat in Greater China appeared first on Pharmaceutical Business review. … [Read more...]

Pharmaceutical company Pfizer has acquired  a privately held company Amplyx Pharmaceuticals for an undisclosed amount. Amplyx is developing treatment for life-threatening diseases caused due to failing immune system. The post Pfizer acquires Amplyx Pharmaceuticals appeared first on Pharmaceutical Business review. … [Read more...]